Compare NRIX & XE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRIX | XE |
|---|---|---|
| Founded | 2009 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.1B |
| IPO Year | 2020 | 2026 |
| Metric | NRIX | XE |
|---|---|---|
| Price | $14.76 | $10.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $33.50 | $25.72 |
| AVG Volume (30 Days) | 3.4M | ★ 5.6M |
| Earning Date | 10-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.26 | N/A |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | $786.93 | $132.70 |
| Revenue Next Year | N/A | $293.45 |
| P/E Ratio | $4.52 | ★ N/A |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $12.61 | $8.68 |
| 52 Week High | $28.23 | $23.99 |
| Indicator | NRIX | XE |
|---|---|---|
| Relative Strength Index (RSI) | 25.08 | 40.67 |
| Support Level | $14.65 | $10.04 |
| Resistance Level | $17.47 | $12.08 |
| Average True Range (ATR) | 1.22 | 0.95 |
| MACD | -0.77 | 0.20 |
| Stochastic Oscillator | 0.23 | 46.91 |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
X-Energy Inc operates as a designer of small modular nuclear reactors (SMRs) and nuclear fuel technologies. Its products include the Xe-100 high-temperature gas-cooled reactor and TRISO-X particle fuel, which are being developed for applications in grid power, industrial facilities, and artificial intelligence infrastructure.